All lobbying filings

EMD MILLIPORE CORPORATION

Lobbying for EMD MILLIPORE CORPORATION · Manufacturing of preparation, separation, filtration and monitoring life sciences tools.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · $100,000.00 expenses · posted Jul 20, 2026

Official filing document

Lobbying activity 2

Tariff (miscellaneous tariff bills)

Section 301 Tariffs - Discussions related to the impact of Reciprocal Tariffs on U.S. biomanufacturing Section 232 Tariffs - Discussions related to the impact of Pharmaceutical Tariffs on U.S. biomanufacturing

Manufacturing

General discussions related to federal procurement policy

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.